InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,011.12
(
-0.22%
)
US TECH 100
16,820.40
(
-0.68%
)
Dow Jones
37,775.38
(
0.06%
)
Brent Oil
87.11
(
0.80%
)
Bitcoin
64,783.73
(
2.01%
)
Post# of 251525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 356
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: None

Tuesday, 03/14/2017 11:50:42 AM

Tuesday, March 14, 2017 11:50:42 AM

Post# of 251525
$TPIV: TapImmune Announces Fully Funded Phase 2 Clinical Study of HER2-Targeted Vaccine in Early Breast Cancer

http://finance.yahoo.com/news/tapimmune-announces-fully-funded-phase-131500409.html



Also, live webcast today at 4:30 pm ET

https://finance.yahoo.com/news/tapimmune-host-inaugural-quarterly-business-141500895.html





IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up